Rakuten Medical, Inc.
October 18, 2023
Franciscan C
Oncology
Rakuten Medical is a private biotechnology firm that is developing cancer therapies with the ability to target cancer cells and induce immunogenic cell death, using a photoimmunotherapy platform with a lead program that received approval in Japan in 2020 and recently showed promising early results in combination with anti-PD-1 therapy in patients with locoregional and/or metastatic HNSCC.
Company Type
Privately Funded
Website
https://rakuten-med.com/us/
CEO/Top Company Official
Mickey Mikitani
Lead Product in Development
ASP-1929 (anti-EGFR-IR700 conjugate)
Number Of Unlicensed Products
4
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)